News:

Dohmen welcomes Lynda Parker, Chief Business Development Officer, Direct-to-Pat...

Dohmen has appointed Lynda Parker as its new Chief Business Development Officer, Direct-to-Patient Services for Dohmen Life Science Services. With more than 30 years of experience, she’s successfully led product commercialization and helped orphan drug manufacturers overcome the challenges faced ...

Lynda Parker

What's new